Meeting
2020 ASCO Virtual Scientific Program
Clonal hematopoiesis in the bone marrow and blood of healthy volunteers.
Authors
Pierre Hirsch
Sorbonne Université, UMRS 938, APHP, Hôpital Saint-Antoine, Paris, France
Pierre Hirsch , Noémie Ravalet , Helene Guermouche , Nathalie Gallay , Emmanuel Gyan , François Delhommeau , Olivier Herault
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Other Leukemia, Myelodysplastic Syndromes, and Allotransplant
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7517)
DOI
10.1200/JCO.2020.38.15_suppl.7517
Abstract #
7517
Poster Bd #
290
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clonal hematopoiesis (CH) associated mutations in patients with advanced solid tumors enrolled in phase I clinical trials.
First Author: Julieta Rodriguez
Poster
2023 ASCO Annual Meeting
Germline mutations and the presence of clonal hematopoiesis of indeterminate potential (CHIP) in 20,963 patients with BRCA-associated cancers.
First Author: Catherine Handy Marshall
Poster
2021 ASCO Annual Meeting
Prevalence of inferred clonal hematopoiesis (CH) detected on comprehensive genomic profiling (CGP) of solid tumor tissue or circulating tumor DNA (ctDNA).
First Author: Emmanuel S. Antonarakis
Poster
2019 ASCO Annual Meeting
Clonal hematopoiesis of indeterminate potential (CHIP) mutations in solid tumor malignancies.
First Author: Madison Conces